EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4‐Mediated Acute Hepatitis

Weiwei Zhu, Yaqian Cui, Yongqiang Zhou, Yihui Zheng, Lijiang Huang, Leiming Jin, Qianhui Zhang, Pan Chen, Mengsha Lin, Jiaxi Ye, Yongqiang Xiong, Joo Young Huh und 4 weitere

Advanced Science · 2026-06 · 13 (32)

DOI: 10.1002/advs.202521164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.03.2026. Verfasst von Weiwei Zhu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Hepatocytes, Brain-Derived Neurotrophic Factor, Hepatitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute hepatitis is a major pathological process underlying acute liver injury (ALI) and acute liver failure (ALF), both of which are associated with high mortality. Yet, no effective treatment is currently available, underscoring the pressing need for novel therapeutic targets. By integrating multiple transcriptomic datasets, this study finds that the expression of brain‐derived neurotrophic factor (BDNF) is consistently downregulated in hepatocytes across various ALI/ALF models. Mechanistically, this downregulation is attributed to transcriptional repression of BDNF by RE1‐silencing transcription factor. Restoration of endogenous BDNF or exogenous administration of recombinant BDNF significantly alleviates LPS/DGal‐induced ALI/ALF. Correlation analysis and proteomic profiling reveal that BDNF exerts potent anti‐inflammatory effects by directly binding to and antagonizing Toll‐like receptor 4 (TLR4) on macrophages. Structural analysis identifies amino acids 233–244 of BDNF as the key functional domain responsible for this effect. A synthetic 12‐mer peptide derived from this region, termed BDP12, retains TLR4‐antagonizing ability, demonstrating strong anti‐inflammatory efficacy and a favorable safety profile in cultured macrophages and mouse ALI/ALF models. In conclusion, this study identifies hepatocyte‐derived BDNF as an endogenous antagonist of TLR4 and a critical immune checkpoint in acute hepatitis. BDNF and its mimetic peptide BDP12 represent promising therapeutic candidates for treating acute hepatitis‐mediated ALI/ALF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4HepatocytesBrain-Derived Neurotrophic FactorHepatitisLiver Failure, AcuteAnimalsMiceHumansMacrophagesMice, Inbred C57BLDisease Models, AnimalMale

Stichwörter der Autor:innen

Acute hepatitisAcute liver failureBDNFBDNF‐mimetic peptideTLR4

Substanzen

Toll-Like Receptor 4Brain-Derived Neurotrophic FactorTlr4 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Affiliated Cangnan Hospital and Chemical Biology Research Center, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Chemoradiation Oncology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Joint Research Center on Medicine, the Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, Zhejiang, China.

ORCID-Profile: Guang Liang

Förderung

  • National Natural Science Foundation of China
  • Postdoctoral Fellowship Program of CPSF
  • China Postdoctoral Science Foundation
  • Medical and Health Science and Technology Project of Zhejiang Province
  • Science and Technology Plan Project of Wenzhou Municipality

Zitieren

APA

Zhu, W., Cui, Y., Zhou, Y., Zheng, Y., Huang, L., Jin, L., Zhang, Q., Chen, P., Lin, M., Ye, J., Xiong, Y., Huh, J. Y., Hu, X., Li, X., Luo, W., & Liang, G. (2026). Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4‐Mediated Acute Hepatitis. Advanced Science, 13(32). https://doi.org/10.1002/advs.202521164

Vancouver

Zhu W, Cui Y, Zhou Y, Zheng Y, Huang L, Jin L, et al. Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4‐Mediated Acute Hepatitis. Advanced Science. 2026;13(32). doi:10.1002/advs.202521164

BibTeX
@article{Zhu2026,
  author = {Zhu, Weiwei and Cui, Yaqian and Zhou, Yongqiang and Zheng, Yihui and Huang, Lijiang and Jin, Leiming and Zhang, Qianhui and Chen, Pan and Lin, Mengsha and Ye, Jiaxi and Xiong, Yongqiang and Huh, Joo Young and Hu, Xiang and Li, Xiaokun and Luo, Wu and Liang, Guang},
  title = {Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4‐Mediated Acute Hepatitis},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {32},
  doi = {10.1002/advs.202521164}
}
Kostenlos starten →